No high-quality randomized controlled trials specifically evaluate SubQ glutathione dosing regimens, frequency, or comparative efficacy versus IV or oral routes
Sciwind is also developing XW014, a small molecule GLP-1 receptor agonist, and XW017, an injectable GIP receptor agonist
GHK-Cu is one of the most well-studied peptides available in clinical practice
As an example, poorly controlled diabetes can lead to dangerously low blood sugar underwater (see the Underwater Wellness column in our December issue for tips on diving with diabetes)
Do endocrinologists treat thyroid-related weight gain
If you are dosing GHK-Cu every 48 hours and miss a dose by 1224 hours, residual tissue-level activity from the prior dose is likely present but diminishing